In 2023, Ozempic and Wegovy sales collectively reached nearly $18.5 billion, making up over half of Novo Nordisks total sales (about $34 billion) that year
I have had medications I did not like and was easily able to try new ones and was fully informed on medication instruction, educated on how the medication works, and educated on side effects
GLP-1 A
LW: Writingoriginal draft, Resources, Data curation, Conceptualization
For women of reproductive years living with type 2 diabetes, the relative merits of using non-insulin pharmacotherapies vs diabetes technology (dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists and sodiumglucose cotransporter 2 inhibitors) are unknown
Bringing it into our core assortment allows us to build out that destination in a more impactful way, says Espinoza